Tuberculosis therapy in Mumbai: Critical importance of drug-susceptibility testing.
作者信息
Daftary Amrita, Pai Madhukar
机构信息
McGill International TB Centre, McGill University, Montreal, Canada E-mail:
出版信息
Lung India. 2016 May-Jun;33(3):251-2. doi: 10.4103/0970-2113.180799.
Abstract
摘要
相似文献
1
Tuberculosis therapy in Mumbai: Critical importance of drug-susceptibility testing.孟买的结核病治疗：药敏试验的至关重要性。
Lung India. 2016 May-Jun;33(3):251-2. doi: 10.4103/0970-2113.180799.
2
Changing prevalence and resistance patterns in children with drug-resistant tuberculosis in Mumbai.孟买耐药性肺结核患儿中不断变化的患病率和耐药模式。
Paediatr Int Child Health. 2017 May;37(2):135-138. doi: 10.1080/20469047.2016.1214796. Epub 2016 Aug 9.
3
Surgical interventions for pulmonary tuberculosis in Mumbai, India: surgical outcomes and programmatic challenges.印度孟买肺结核的外科干预措施：手术结果及项目挑战
Public Health Action. 2016 Sep;6(3):193-198. doi: 10.5588/pha.16.0043. Epub 2016 Sep 21.
4
Effect of public-private interface agency in Patna and Mumbai, India: Does it alter durations and delays in care seeking for drug-sensitive pulmonary tuberculosis?印度巴特那和孟买公私合营中介机构的作用：它是否会改变药物敏感型肺结核患者的就诊时长和延误情况？
Gates Open Res. 2020 Apr 9;4:32. doi: 10.12688/gatesopenres.13113.1. eCollection 2020.
5
Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape.孟买、摩尔多瓦和东开普之间结核耐药相关突变的频率与分布
Antimicrob Agents Chemother. 2016 Jun 20;60(7):3994-4004. doi: 10.1128/AAC.00222-16. Print 2016 Jul.
6
Pathway to care for drug resistant tuberculosis cases identified during a retrospective study conducted in high TB burden wards in Mumbai.在孟买结核病高负担病房进行的一项回顾性研究中确定的耐多药结核病病例的护理途径。
Gates Open Res. 2018 May 10;2:9. doi: 10.12688/gatesopenres.12785.2. eCollection 2018.
7
Spoligotyping of Mycobacterium tuberculosis isolates from patients with pulmonary tuberculosis in Mumbai, India.印度孟买肺结核患者结核分枝杆菌分离株的间隔寡核苷酸分型。
Res Microbiol. 2005 May;156(4):588-96. doi: 10.1016/j.resmic.2005.01.005. Epub 2005 Feb 7.
8
Increasing incidence of fluoroquinolone-resistant Mycobacterium tuberculosis in Mumbai, India.印度孟买耐氟喹诺酮结核分枝杆菌的发病率不断上升。
Int J Tuberc Lung Dis. 2009 Jan;13(1):79-83.
9
[Mycobacterial tests].[分枝杆菌检测]
Kekkaku. 2008 Jan;83(1):43-59.
10
Drug susceptibility testing of Mycobacterium Avium subsp. Avium isolates from naturally infected domestic pigeons to avian tuberculosis.从自然感染的家鸽中分离出的鸟分枝杆菌鸟亚种菌株对禽结核病的药敏试验。
Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S217-S218. doi: 10.1016/j.ijmyco.2016.09.018. Epub 2016 Oct 28.
引用本文的文献
1
Use of standardised patients to assess tuberculosis case management by private pharmacies in Patna, India: A repeat cross-sectional study.利用标准化患者评估印度巴特那私人药房的结核病病例管理：一项重复横断面研究。
PLOS Glob Public Health. 2023 May 26;3(5):e0001898. doi: 10.1371/journal.pgph.0001898. eCollection 2023.
2
Can community pharmacists improve tuberculosis case finding? A mixed methods intervention study in India.社区药剂师能否改善结核病病例发现情况？印度的一项混合方法干预研究。
BMJ Glob Health. 2019 May 13;4(3):e001417. doi: 10.1136/bmjgh-2019-001417. eCollection 2019.
3
Inconsistency in the reporting of antitubercular drug susceptibility tests in an endemic region.在一个结核病流行地区，抗结核药物敏感性试验报告存在不一致性。
Lung India. 2017 Sep-Oct;34(5):427-429. doi: 10.4103/0970-2113.213840.
4
India's fight against tuberculosis: How can chest physicians help?印度抗击结核病：胸科医生如何提供帮助？
Lung India. 2017 Mar-Apr;34(2):120-121. doi: 10.4103/lungindia.lungindia_57_17.
本文引用的文献
1
Possible impact of the standardized Category IV regimen on multidrug-resistant tuberculosis patients in Mumbai.标准化IV类治疗方案对孟买耐多药结核病患者的潜在影响。
Lung India. 2016 May-Jun;33(3):253-6. doi: 10.4103/0970-2113.180800.
2
Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV.重塑依从性：迈向以患者为中心的耐多药结核病和艾滋病治疗模式
Int J Tuberc Lung Dis. 2016 Apr;20(4):430-4. doi: 10.5588/ijtld.15.0360.
3
"When Treatment Is More Challenging than the Disease": A Qualitative Study of MDR-TB Patient Retention.“当治疗比疾病更具挑战性时”：耐多药结核病患者留存率的定性研究
PLoS One. 2016 Mar 9;11(3):e0150849. doi: 10.1371/journal.pone.0150849. eCollection 2016.
4
TB control: challenges and opportunities for India.结核病防控：印度面临的挑战与机遇
Trans R Soc Trop Med Hyg. 2016 Mar;110(3):158-60. doi: 10.1093/trstmh/trw003.
5
Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients' experiences in the era of rapid molecular diagnostic tests.耐多药结核病的诊断途径及治疗起始：快速分子诊断检测时代患者经历的定性比较
BMC Health Serv Res. 2015 Oct 28;15:488. doi: 10.1186/s12913-015-1145-0.
6
Moving Beyond Directly Observed Therapy for Tuberculosis.超越结核病直接观察治疗
PLoS Med. 2015 Sep 15;12(9):e1001877. doi: 10.1371/journal.pmed.1001877. eCollection 2015 Sep.
7
Quality of tuberculosis care in India: a systematic review.印度结核病护理质量：一项系统综述。
Int J Tuberc Lung Dis. 2015 Jul;19(7):751-63. doi: 10.5588/ijtld.15.0186.
8
Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India.在印度分散式公共卫生环境中使用Xpert MTB/RIF及其对肺结核和耐多药肺结核病例发现的影响。
PLoS One. 2015 May 21;10(5):e0126065. doi: 10.1371/journal.pone.0126065. eCollection 2015.
9
India should screen all tuberculosis patients for drug resistant disease at diagnosis.印度应在诊断时对所有结核病患者进行耐药性疾病筛查。
BMJ. 2015 Mar 23;350:h1235. doi: 10.1136/bmj.h1235.
10
Resistance patterns among multidrug-resistant tuberculosis patients in greater metropolitan Mumbai: trends over time.孟买大都市区耐多药结核病患者的耐药模式：随时间变化的趋势
PLoS One. 2015 Jan 21;10(1):e0116798. doi: 10.1371/journal.pone.0116798. eCollection 2015.
Zotero 插件